{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T05:11:10Z","timestamp":1789621870532,"version":"build-2803163510"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T00:00:00Z","timestamp":1669939200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Low serum progesterone concentration on frozen embryo transfer (FET) day in hormone replacement therapy (HRT) cycles results in lower reproductive outcomes. Recent studies showed the efficiency of a \u201crescue protocol\u2019\u2019 to restore reproductive outcomes in these patients. Here, we compared reproductive outcomes in HRT FET cycles in women with low serum progesterone levels who received individualized luteal phase support (iLPS) and in women with adequate serum progesterone levels who underwent <jats:italic>in vitro<\/jats:italic> fertilization for pre-implantation genetic testing for structural rearrangements or monogenic disorders.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>This retrospective cohort study included women (18-43 years of age) undergoing HRT FET cycles with pre-implantation genetic testing at Montpellier University Hospital between June 2020 and May 2022.\u00a0A standard HRT was used: vaginal micronized estradiol (6mg\/day) followed by vaginal micronized progesterone (VMP; 800 mg\/day). Serum progesterone was measured after four doses of VMP: if &amp;lt;11ng\/ml, 25mg\/day subcutaneous progesterone or 30mg\/day oral dydrogesterone was introduced.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>125 HRT FET cycles were performed in 111 patients. Oral\/subcutaneous progesterone supplementation concerned 39 cycles (n=20 with subcutaneous progesterone and n=19 with oral dydrogesterone). Clinical and laboratory parameters of the cycles were comparable between groups. The ongoing pregnancy rate (OPR) was 41.03% in the supplemented group and 18.60% in the non-supplemented group (p= 0.008). The biochemical pregnancy rate and miscarriages rate tended to be higher in the non-supplemented group versus the supplemented group: 13.95% versus 5.13% and 38.46% versus 15.79% (p=0.147 and 0.182 respectively). Multivariate logistic regression analysis found that progesterone supplementation was significantly associated with higher OPR \u200b\u200b (adjusted OR = 3.25, 95% CI [1.38 \u2013 7.68], p=0.007).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In HRT FET cycles, progesterone supplementation in patients with serum progesterone concentration &amp;lt;11 ng\/mL after four doses of VMP significantly increases the OPR.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2022.1051857","type":"journal-article","created":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T10:10:54Z","timestamp":1669975854000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["Individualized luteal phase support based on serum progesterone levels in frozen-thawed embryo transfer cycles maximizes reproductive outcomes in a cohort undergoing preimplantation genetic testing"],"prefix":"10.3389","volume":"13","author":[{"given":"Bertille","family":"du Boulet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noemie","family":"Ranisavljevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Mollevi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Bringer-Deutsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Brouillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tal","family":"Anahory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,12,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006359.pub3","article-title":"Endometrial preparation for women undergoing embryo transfer with frozen embryos or embryos derived from donor oocytes","volume":"10","author":"Glujovsky","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1093\/hropen\/hoac007","article-title":"Impact of endometrial preparation on early pregnancy loss and live birth rate after frozen embryo transfer: a large multicenter cohort study (14 421 frozen cycles)","volume":"2022","author":"Vinsonneau","year":"2022","journal-title":"Hum Reprod Open"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-128X(00)00121-5","article-title":"Pharmacokinetics of the progesterone-containing vaginal tablet and its use in assisted reproduction","volume":"65","author":"Levy","year":"2000","journal-title":"Steroids"},{"key":"B4","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.rbmo.2020.03.001","article-title":"Factors associated with serum progesterone concentrations the day before cryopreserved embryo transfer in artificial cycles","volume":"40","author":"Gonz\u00e1lez-Foruria","year":"2020","journal-title":"Reprod BioMed Online."},{"key":"B5","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.fertnstert.2021.08.040","article-title":"Individualized luteal phase support normalizes live birth rate in women with low progesterone levels on the day of embryo transfer in artificial endometrial preparation cycles","volume":"117","author":"Labarta","year":"2022","journal-title":"Fertil Steril."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/ajo.12757","article-title":"Progesterone concentrations and dosage with frozen embryo transfers - what\u2019s best","volume":"58","author":"Basnayake","year":"2018","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2018.08.022","article-title":"Progesterone levels on pregnancy test day after hormone replacement therapy-cryopreserved embryo transfer cycles and related reproductive outcomes","volume":"37","author":"Alsbjerg","year":"2018","journal-title":"Reprod BioMed Online"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2022.05.022","article-title":"Serum progesterone concentrations are reduced in obese women on the day of embryo transfer","volume":"45","author":"Bellver","year":"2022","journal-title":"Reprod BioMed Online"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2018.11.026","article-title":"Serum progesterone concentration and live birth rate in frozen-thawed embryo transfers with hormonally prepared endometrium","volume":"38","author":"C\u00e9drin-Durnerin","year":"2019","journal-title":"Reprod BioMed Online"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-3937","article-title":"Progesterone pharmacokinetics and pharmacodynamics with 3 dosages and 2 regimens of an effervescent micronized progesterone vaginal insert","volume":"99","author":"Paulson","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/685281","article-title":"Sexual absorption of vaginal progesterone: A randomized control trial","volume":"2015","author":"Merriam","year":"2015","journal-title":"Int J Endocrinol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s10815-014-0199-y","article-title":"Serum progesterone concentration on day of embryo transfer in donor oocyte cycles","volume":"31","author":"Brady","year":"2014","journal-title":"J Assist Reprod Genet"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dex316","article-title":"Low serum progesterone on the day of embryo transfer is associated with a diminished ongoing pregnancy rate in oocyte donation cycles after artificial endometrial preparation: a prospective study","volume":"32","author":"Labarta","year":"2017","journal-title":"Hum Reprod"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deaa322","article-title":"Impact of low serum progesterone levels on the day of embryo transfer on pregnancy outcome: a prospective cohort study in artificial cycles with vaginal progesterone","volume":"36","author":"Labarta","year":"2021","journal-title":"Hum Reprod"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2015.05.005","article-title":"Mid-luteal serum progesterone concentrations govern implantation rates for cryopreserved embryo transfers conducted under hormone replacement","volume":"31","author":"Yovich","year":"2015","journal-title":"Reprod BioMed"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2021.07.002","article-title":"Serum luteal phase progesterone in women undergoing frozen embryo transfer in assisted conception: a systematic review and meta-analysis","volume":"116","author":"Melo","year":"2021","journal-title":"Fertil Steril"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.892753","article-title":"Low luteal serum progesterone levels are associated with lower ongoing pregnancy and live birth rates in ART: Systematic review and meta-analyses","volume":"13","author":"Ranisavljevic","year":"2022","journal-title":"Front Endocrinol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2009.06.014","article-title":"Single and multidose pharmacokinetic study of a vaginal micronized progesterone insert (Endometrin) compared with vaginal gel in healthy reproductive-aged female subjects","volume":"94","author":"Blake","year":"2010","journal-title":"Fertil Steril"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/s0015-0282(16)46095-4","article-title":"The value of a single serum progesterone measurement in the midluteal phase as a criterion of a potentially fertile cycle (\u201covulation\u201d) derived form treated and untreated conception cycles","volume":"37","author":"Hull","year":"1982","journal-title":"Fertil Steril."},{"key":"B20","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.rbmo.2021.04.011","article-title":"Subcutaneous luteal phase progesterone rescue rectifies ongoing pregnancy rates in hormone replacement therapy vitrified-warmed blastocyst transfer cycles","volume":"43","author":"Yarali","year":"2021","journal-title":"Reprod BioMed Online"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deab031","article-title":"Individualised luteal phase support in artificially prepared frozen embryo transfer cycles based on serum progesterone levels: a prospective cohort study","volume":"36","author":"\u00c1lvarez","year":"2021","journal-title":"Hum Reprod"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2022.05.023","article-title":"The importance of serum progesterone concentration at embryo transfer day and effect of rescue additional progesterone during programmed artificial frozen embryo transfer cycles","volume":"45","author":"Ozcan","year":"2022","journal-title":"Reprod BioMed Online"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2017.11.004","article-title":"Vitrified blastocyst transfer cycles with the use of only vaginal progesterone replacement with endometrin have inferior ongoing pregnancy rates: results from the planned interim analysis of a three-arm randomized controlled noninferiority trial","volume":"109","author":"Devine","year":"2018","journal-title":"Fertil Steril."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-016-4217-4","article-title":"Comparison of four protocols for luteal phase support in frozen-thawed embryo transfer cycles: a randomized clinical trial","volume":"295","author":"Zarei","year":"2017","journal-title":"Arch Gynecol Obstet"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009154.pub3","article-title":"Luteal phase support for assisted reproduction cycles","volume":"7","author":"van der Linden","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1093\/humrep\/dex266","article-title":"A phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization","volume":"32","author":"Tournaye","year":"2017","journal-title":"Hum Reprod"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dey306","article-title":"Oral dydrogesterone versus intravaginal micronized progesterone gel for luteal phase support in IVF: a randomized clinical trial","volume":"33","author":"Griesinger","year":"2018","journal-title":"Hum Reprod"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0241044","article-title":"Dydrogesterone as an oral alternative to vaginal progesterone for IVF luteal phase support: A systematic review and individual participant data meta-analysis","volume":"15","author":"Griesinger","year":"2020","journal-title":"PloS One"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.5935\/1518-0557.20180018","article-title":"Oral dydrogesterone vs. vaginal progesterone capsules for luteal-phase support in women undergoing embryo transfer: a systematic review and meta-analysis","volume":"22","author":"Barbosa","year":"2018","journal-title":"JBRA Assist Reprod"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deac045","article-title":"Dydrogesterone and 20\u03b1-dihydrodydrogesterone plasma levels on day of embryo transfer and clinical outcome in an anovulatory programmed frozen-thawed embryo transfer cycle: a prospective cohort study","volume":"37","author":"Neumann","year":"2022","journal-title":"Hum Reprod"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deab184","article-title":"Analysis of serum and endometrial progesterone in determining endometrial receptivity","volume":"36","author":"Labarta","year":"2021","journal-title":"Hum Reprod"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3390\/life11121357","article-title":"Implantation failures and miscarriages in frozen embryo transfers timed in hormone replacement cycles (HRT): A narrative review","volume":"11","author":"De Ziegler","year":"2021","journal-title":"Life (Basel)."},{"key":"B33","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ygcen.2016.03.003","article-title":"Immune-endocrine crosstalk during pregnancy","volume":"242","author":"Nair","year":"2017","journal-title":"Gen Comp Endocrinol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3109\/09513590.2012.736560","article-title":"Pharmacokinetics and safety profile of a novel progesterone aqueous formulation administered by the s.C. route","volume":"29","author":"Sator","year":"2013","journal-title":"Gynecol Endocrinol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/s10815-015-0546-7","article-title":"Serum progesterone levels greater than 20 Ng\/Dl on day of embryo transfer are associated with lower live birth and higher pregnancy loss rates","volume":"32","author":"Kofinas","year":"2015","journal-title":"J Assist Reprod Genet"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deab093","article-title":"Micronized progesterone plus dydrogesterone versus micronized progesterone alone for luteal phase support in frozen-thawed cycles (MIDRONE): a prospective cohort study","volume":"36","author":"Vuong","year":"2021","journal-title":"Hum Reprod"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.1051857\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T10:10:55Z","timestamp":1669975855000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.1051857\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,2]]},"references-count":36,"alternative-id":["10.3389\/fendo.2022.1051857"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.1051857","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,2]]},"article-number":"1051857"}}